|Bid||0.5420 x 800|
|Ask||0.5502 x 1000|
|Day's Range||0.5400 - 0.5778|
|52 Week Range||0.5200 - 1.7900|
|Beta (5Y Monthly)||3.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2021 - Nov 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.70|
EMERYVILLE, Calif., September 29, 2021--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation today, Wednesday, September 29, 2021 beginning at 4:30 p.m. Eastern time.
EMERYVILLE, Calif., September 28, 2021--NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor
EMERYVILLE, Calif., September 08, 2021--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. The company presentation will be posted to the "Events" page on the company website.